Cargando…
Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738067/ https://www.ncbi.nlm.nih.gov/pubmed/31123346 http://dx.doi.org/10.1038/s41416-019-0487-5 |
_version_ | 1783450776229642240 |
---|---|
author | Serrano, César Mariño-Enríquez, Adrián Tao, Derrick L. Ketzer, Julia Eilers, Grant Zhu, Meijun Yu, Channing Mannan, Aristotle M. Rubin, Brian P. Demetri, George D. Raut, Chandrajit P. Presnell, Ajia McKinley, Arin Heinrich, Michael C. Czaplinski, Jeffrey T. Sicinska, Ewa Bauer, Sebastian George, Suzanne Fletcher, Jonathan A. |
author_facet | Serrano, César Mariño-Enríquez, Adrián Tao, Derrick L. Ketzer, Julia Eilers, Grant Zhu, Meijun Yu, Channing Mannan, Aristotle M. Rubin, Brian P. Demetri, George D. Raut, Chandrajit P. Presnell, Ajia McKinley, Arin Heinrich, Michael C. Czaplinski, Jeffrey T. Sicinska, Ewa Bauer, Sebastian George, Suzanne Fletcher, Jonathan A. |
author_sort | Serrano, César |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6738067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-67380672020-01-17 Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours Serrano, César Mariño-Enríquez, Adrián Tao, Derrick L. Ketzer, Julia Eilers, Grant Zhu, Meijun Yu, Channing Mannan, Aristotle M. Rubin, Brian P. Demetri, George D. Raut, Chandrajit P. Presnell, Ajia McKinley, Arin Heinrich, Michael C. Czaplinski, Jeffrey T. Sicinska, Ewa Bauer, Sebastian George, Suzanne Fletcher, Jonathan A. Br J Cancer Correction Nature Publishing Group UK 2019-05-23 2019-07-30 /pmc/articles/PMC6738067/ /pubmed/31123346 http://dx.doi.org/10.1038/s41416-019-0487-5 Text en © Cancer Research UK 2019 https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correction Serrano, César Mariño-Enríquez, Adrián Tao, Derrick L. Ketzer, Julia Eilers, Grant Zhu, Meijun Yu, Channing Mannan, Aristotle M. Rubin, Brian P. Demetri, George D. Raut, Chandrajit P. Presnell, Ajia McKinley, Arin Heinrich, Michael C. Czaplinski, Jeffrey T. Sicinska, Ewa Bauer, Sebastian George, Suzanne Fletcher, Jonathan A. Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours |
title | Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours |
title_full | Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours |
title_fullStr | Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours |
title_full_unstemmed | Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours |
title_short | Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours |
title_sort | correction: complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738067/ https://www.ncbi.nlm.nih.gov/pubmed/31123346 http://dx.doi.org/10.1038/s41416-019-0487-5 |
work_keys_str_mv | AT serranocesar correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT marinoenriquezadrian correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT taoderrickl correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT ketzerjulia correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT eilersgrant correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT zhumeijun correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT yuchanning correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT mannanaristotlem correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT rubinbrianp correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT demetrigeorged correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT rautchandrajitp correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT presnellajia correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT mckinleyarin correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT heinrichmichaelc correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT czaplinskijeffreyt correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT sicinskaewa correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT bauersebastian correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT georgesuzanne correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours AT fletcherjonathana correctioncomplementaryactivityoftyrosinekinaseinhibitorsagainstsecondarykitmutationsinimatinibresistantgastrointestinalstromaltumours |